Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sorafenib exhibits antitumor activity in hematological malignancies in phase I trial

June 25, 2010

Eisai's anticancer agent eribulin mesilate receives priority review status in Japan

June 23, 2010

StemEx receives FDA fast track designation

June 23, 2010

OncoGenex begins phase III custirsen sodium trial in metastatic prostate cancer

June 23, 2010

Cellceutix concludes preclinical studies of Kevetrin in multidrug-resistant cancer cells

June 23, 2010

TH-302/doxorubicin combination is safe in phase I/II trial in soft tissue sarcoma

June 23, 2010

Novel PDK1 inhibitors claimed by MSD for cancer therapy

June 23, 2010

Exelixis regains rights to XL-184

June 22, 2010

FDA advises on phase III palifosfamide trial in metastatic soft tissue sarcoma

June 22, 2010

PX-478 shows antitumor activity in phase I trial in advanced solid tumors

June 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...